CAI
Caris Life Sciences, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +3.2% · net new positions -5.6% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Coatue Management ✦ | 10.14M | 0.0% | $306.80M | 0.8% | Held | 2 | SEC ↗ ×3 |
| 2 | Fidelity (FMR) ✦ | 9.63M | +11.6% | $291.41M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | T. Rowe Price ✦ | 6.92M | +2.4% | $209.47M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Millennium Management ✦ | 3.94M | +12.1% | $119.13M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | JPMorgan Chase ✦ | 1.72M | n/a | $51.92M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 6 | Morgan Stanley ✦ | 1.53M | n/a | $46.42M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 7 | BlackRock ✦ (passive) | 647.08K | +109.3% | $19.57M | 0.0% | ▲ Add | 2 | SEC ↗ ×8 |
| 8 | Geode Capital Management ✦ (passive) | 398.33K | +69.3% | $12.05M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 9 | Goldman Sachs Group ✦ | 282.21K | n/a | $8.54M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Point72 Asset Management ✦ | 246.62K | -46.2% | $7.46M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | ARK Investment Management ✦ | 245.35K | +421.5% | $7.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 225.10K | New | $6.81M | 0.0% | New | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passive) | 175.54K | +17.0% | $5.31M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 14 | State Street Global Advisors ✦ (passive) | 155.34K | New | $4.70M | 0.0% | New | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 82.97K | +119.1% | $2.51M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 16 | Soros Fund Management ✦ | 55.65K | +11.3% | $1.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 49.78K | +563.8% | $1.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 33.20K | New | $1.00M | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $6.81M | 0.0% |
| State Street Global Advisors | $4.70M | 0.0% |
| Gotham Asset Management | $1.00M | 0.0% |
Exited
| Capital World Investors | $26.72M | was 0.0% |
| Norges Bank | $10.02M | was 0.0% |
| Citadel Advisors | $9.13M | was 0.0% |
| Adage Capital Partners | $4.01M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 200 holders, 153.41M shares, $2.53B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 7.50K sh · $238,626
Officer, Director · 400.00K sh · $12.13M
Officer · 119.21K sh · $2.95M
Officer · 393.10K sh · $9.73M
Officer · 84.90K sh · $2.15M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology